The global molecular diagnostics market size is projected to reach US$ 15 Billion by 2027 at a CAGR of 8.4%.
Molecular diagnostic tests are wont to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, etc. to further diagnose the disease. These are cumulative techniques for analyzing biological markers at the molecular level, like genome and proteome. These techniques are used for diagnosis of the varied infectious diseases, cancer, etc. and is additionally wont to check the genetic predisposition to a disease. Molecular diagnostic tests are the elementary a part of a successful health care system. Molecular diagnostic tests deliver critical information that helps the healthcare providers and patients to form the proper medical decisions for better outcome of a procedure.
Nevertheless, the rising prevalence of the communicable disease, growing awareness regarding molecular diagnostic techniques, and advancement in molecular diagnostics are the first factors liable for market growth during the forecast period. The increasing prevalence of infectious diseases, rising incidence of various sorts of cancer, and advancements in molecular diagnostic techniques are the main drivers propelling market growth. Nevertheless, stringent regulatory policies constrain the expansion of the market.
The global Molecular Diagnostics market is segregated on the basis of Application as Genetic Tests, Other Applications, Oncology, and Infectious Diseases. Based on Technology the global Molecular Diagnostics market is segmented in in Situ Hybridization, DNA Microarray, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, and Other Technologies. Based on Product & Service the global Molecular Diagnostics market is segmented in Instruments, Services & Software, and Reagents & Kits. Based on End User, the global Molecular Diagnostics market is segmented in Reference Laboratories, Hospital & Academic Laboratories, and Other End Users.
The global Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, and others are among the major players in the global Molecular Diagnostics market.
The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
Molecular Diagnostics Market has been segmented as below:
Molecular Diagnostics Market, By Application
Molecular Diagnostics Market, By Technology
Molecular Diagnostics Market, By Product & Service
Molecular Diagnostics Market, By End User
Molecular Diagnostics Market, By Region
Molecular Diagnostics Market, By Company
The report covers:
Report Scope:
The global Molecular Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Molecular Diagnostics market share. Major industry players with significant revenue share include Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, and others.
Reasons to Buy this Report:
Some of the recent Developments in Molecular Diagnostics market are as follows:
Thermo Fisher Scientific
Abbott Laboratories
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Artificial Intelligence Software Platform Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Molecular Diagnostics Market, By Application
5.1 Introduction
5.2 Genetic Tests
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Other Applications
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Oncology
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Infectious Diseases
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Molecular Diagnostics Market, By Technology
6.1 Introduction
6.2 in Situ Hybridization
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 DNA Microarray
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Polymerase Chain Reaction
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Isothermal Nucleic Acid Amplification Technology
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 DNA Sequencing & Next-Generation Sequencing
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Other Technologies
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. Molecular Diagnostics Market, By Product & Service
7.1 Introduction
7.2 Instruments
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Services & Software
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Reagents & Kits
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Molecular Diagnostics Market, By End User
8.1 Introduction
8.2 Reference Laboratories
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Hospital & Academic Laboratories
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Other End Users
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9. Molecular Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Molecular Diagnostics, By Application
9.2.2 North America Molecular Diagnostics, By Technology
9.2.3 North America Molecular Diagnostics, By Product & Service
9.2.4 North America Molecular Diagnostics, By End User
9.3 Europe
9.3.1 Europe Molecular Diagnostics, By Application
9.3.2 Europe Molecular Diagnostics, By Technology
9.3.3 Europe Molecular Diagnostics, By Product & Service
9.3.4 Europe Molecular Diagnostics, By End User
9.4 Asia-Pacific
9.4.1 Asia-Pacific Molecular Diagnostics, By Application
9.4.2 Asia-Pacific Molecular Diagnostics, By Technology
9.4.3 Asia-Pacific Molecular Diagnostics, By Product & Service
9.4.4 Asia-Pacific Molecular Diagnostics, By End User
9.5 Rest of the World
9.5.1 Rest of the World Molecular Diagnostics, By Application
9.5.2 Rest of the World Molecular Diagnostics, By Technology
9.5.3 Rest of the World Molecular Diagnostics, By Product & Service
9.5.4 Rest of the World Molecular Diagnostics, By End User
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Hologic
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Illumina
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Qiagen
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Roche Diagnostics
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Siemens AG
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Abbott Laboratories
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Agilent Technologies
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Biomérieux Sa
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
11.11 Danaher Corporation
11.11.1 Company Overview
11.11.2 Product/Service Landscape
11.11.3 Financial Overview
11.11.4 Recent Developments
11.12 Diasorin
11.12.1 Company Overview
11.12.2 Product/Service Landscape
11.12.3 Financial Overview
11.12.4 Recent Developments
11.13 Grifols
11.13.1 Company Overview
11.13.2 Product/Service Landscape
11.13.3 Financial Overview
11.13.4 Recent Developments
Molecular Diagnostics Market has been segmented as below:
Molecular Diagnostics Market, By Application
Molecular Diagnostics Market, By Technology
Molecular Diagnostics Market, By Product & Service
Molecular Diagnostics Market, By End User
Molecular Diagnostics Market, By Region
Molecular Diagnostics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
